Amy Du Page
About Amy Du Page
Amy Du Page is a Director at Arcus Biosciences, where she has worked since 2024. She has extensive experience in the biotechnology sector, having held various roles at companies such as Biogen Idec, Rigel, and Aduro Biotech.
Current Role at Arcus Biosciences
Amy Du Page currently serves as the Director at Arcus Biosciences, a position she has held since 2024. In this role, she is responsible for overseeing various aspects of the company's research and development initiatives. Her experience in translational science contributes to her leadership in advancing therapeutic strategies within the organization. Arcus Biosciences focuses on developing innovative cancer therapies, and her role is pivotal in guiding these efforts.
Previous Experience at Arcus Biosciences
Before her current position, Amy Du Page worked at Arcus Biosciences as the Associate Director of Translational Science from 2022 to 2024. During this time, she contributed to the company's research projects aimed at enhancing cancer treatment options. Her background in translational science provided a strong foundation for her subsequent promotion to Director.
Professional Background in Biotech
Amy Du Page has a diverse background in the biotechnology sector. She began her career as a Quality Control Analyst at Berlex Biosciences in 2000. She then transitioned to roles such as Research Associate I at Rigel and Senior Associate Scientist at Biogen Idec. Her experience spans various companies, including Amgen and Aduro Biotech, where she held positions focused on personalized medicine and biomarkers.
Education and Expertise
Amy Du Page earned her PhD in Biology from Brandeis University, completing her studies from 2003 to 2009. This academic background has equipped her with a strong foundation in biological sciences, which she has applied throughout her career in various research and development roles. Her expertise encompasses translational science, personalized medicine, and biomarker development.
Career Timeline
Amy Du Page's career spans over two decades in the biotechnology field. She has held multiple positions, including Principal Scientist at Aruvant and Senior Scientist at 4D Molecular Therapeutics. Her roles have varied from research associate to director, reflecting her growth and increasing responsibilities within the industry. This timeline showcases her commitment to advancing scientific research and development.